ACE-I/ARB Therapy prior to Contrast Exposure: What Should the Clinician Do?
Robert Kalyesubula(Africa Center), Mark A. Perazella(Yale University), Peace Bagasha(Mulago Hospital)
Cited by 22
Related Papers
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|724
Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation
|Radiology|2020|582
Renal Vulnerability to Drug Toxicity
|Clinical Journal of the American Society of Nephrology|2009|402
The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease
|The American Journal of Medicine|2004|393
Drug-induced acute interstitial nephritis
|Nature Reviews Nephrology|2010|376